RxDoctor Payments DataLook up a doctor →

Joshua Bradford, DO

Family Medicine · Saint Albans, WVNPI 1689899510

Payments from drug & device makers

$15,911in general payments, 2019–2025

Across 1,060 payments — averaging $15.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • Amgen$761
  • Boehringer Ingelheim$677
  • plus $7K from 48 others

What the payments were for

  • Food & beverage$15,897100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$15,911 in reported general payments places this provider in the 95th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$145,820
Medicare patients
443
Services billed
2,263

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban525$198,371
JardianceEmpagliflozin154$88,700
OzempicSemaglutide88$85,582
JanuviaSitagliptin Phosphate93$62,218
MounjaroTirzepatide49$50,071
XareltoRivaroxaban78$43,485
TrulicityDulaglutide38$40,195
Tresiba Flextouch U-100Insulin Degludec50$39,069
XifaxanRifaximin23$35,316
RybelsusSemaglutide18$33,325
LinzessLinaclotide37$26,256
FarxigaDapagliflozin Propanediol44$24,708
TradjentaLinagliptin52$22,165
MyrbetriqMirabegron29$21,220
EntrestoSacubitril/Valsartan43$17,518

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$480$211,895568 claims
Novo NordiskOzempic, Rybelsus$2,699$118,907106 claims
Boehringer IngelheimJardiance, Tradjenta$677$110,865206 claims
Lilly USA, LLCMounjaro, Trulicity$1,397$90,26687 claims
MerckJanuvia$364$62,21893 claims
AstraZenecaFarxiga, Symbicort, Brilinta, Atacand$1,018$48,450116 claims
Johnson & JohnsonXarelto$391$43,48578 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$400$35,31623 claims
AbbVieLinzess, Restasis$2,195$31,07951 claims
Astellas Pharma US IncMyrbetriq$463$21,22029 claims
NovartisEntresto$564$17,51843 claims
GSKBreo Ellipta$245$5,98115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Saint Albans

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →